RM, B., JK, L., DM, M., & EM, S. (2019). Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts. Circulation. Heart failure, 12(4), e005565. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005565
Chicago Style (17th ed.) CitationRM, Burke, Lighthouse JK, Mickelsen DM, and Small EM. "Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts." Circulation. Heart Failure 12, no. 4 (2019): e005565. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005565.
MLA (9th ed.) CitationRM, Burke, et al. "Sacubitril/Valsartan Decreases Cardiac Fibrosis in Left Ventricle Pressure Overload by Restoring PKG Signaling in Cardiac Fibroblasts." Circulation. Heart Failure, vol. 12, no. 4, 2019, p. e005565, https://doi.org/10.1161/CIRCHEARTFAILURE.118.005565.